SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-116280
Filing Date
2023-11-09
Accepted
2023-11-09 16:10:56
Documents
15
Period of Report
2023-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2330270d1_8k.htm   iXBRL 8-K 28410
2 EXHIBIT 99.1 tm2330270d1_ex99-1.htm EX-99.1 131110
7 GRAPHIC tm2330270d1_ex99-1img001.jpg GRAPHIC 5260
  Complete submission text file 0001104659-23-116280.txt   404062

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA brns-20231109.xsd EX-101.SCH 3545
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE brns-20231109_def.xml EX-101.DEF 26916
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE brns-20231109_lab.xml EX-101.LAB 36969
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE brns-20231109_pre.xml EX-101.PRE 25540
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2330270d1_8k_htm.xml XML 5159
Mailing Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF
Business Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF 44 (0) 1865 818808
Barinthus Biotherapeutics plc. (Filer) CIK: 0001828185 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40367 | Film No.: 231392496
SIC: 2834 Pharmaceutical Preparations